Controlled glycosylation of therapeutic antibodies in plants.
Recombinant therapeutic monoclonal antibodies (mAb) can be expressed, assembled, and glycosylated in plants. Transgenic plants, producing anti-rabies mAb and anti-colorectal cancer mAb, were obtained from Agrobacterium-mediated transformation. The heavy chain (HC) of anti-rabies mAb was fused to the...
主要な著者: | Tekoah, Y, Ko, K, Koprowski, H, Harvey, D, Wormald, M, Dwek, R, Rudd, P |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2004
|
類似資料
-
Glycosylation and prion protein.
著者:: Rudd, P, 等
出版事項: (2002) -
Exploring functions for glycosylation in host defence using novel oligosaccharide sequencing technology
著者:: Rudd, P, 等
出版事項: (2000) -
Glycosylation changes on serum glycoproteins in ovarian cancer may contribute to disease pathogenesis.
著者:: Saldova, R, 等
出版事項: (2008) -
O-linked glycosylation in focus
著者:: Van den Steen, P, 等
出版事項: (2000) -
The impact of glycosylation on the biological function and structure of human immunoglobulins.
著者:: Arnold, J, 等
出版事項: (2007)